Journal article
Nanotechnology in Radiation Oncology
Hematology/oncology clinics of North America, Vol.33(6), pp.1071-1093
12/2019
DOI: 10.1016/j.hoc.2019.08.002
PMCID: PMC6981287
PMID: 31668207
Abstract
Nanotechnology has made remarkable contributions to clinical oncology. Nanotherapeutics and diagnostic tools have distinctive characteristics which allow them superior abilities to deliver therapeutics and imaging agents for radiation oncology. Compared to solid biopsies and imaging, the analysis of circulating tumor cells (CTCs) offers a more rapid, real-time, and less invasive method to monitor the dynamic molecular profiles of tumors. The potential of CTCs to be translated as a novel cancer biomarker has been demonstrated in numerous clinical studies. This review will discuss clinical applications of nanomaterials in radiation oncology and the implication of CTCs in cancer detection and monitoring.
Details
- Title: Subtitle
- Nanotechnology in Radiation Oncology
- Creators
- Bo Sun - University of North Carolina at Chapel HillC. Tilden Hagan - UNC/NCSU Joint Department of Biomedical EngineeringJoseph Caster - University of IowaAndrew Z. Wang - University of North Carolina at Chapel Hill
- Resource Type
- Journal article
- Publication Details
- Hematology/oncology clinics of North America, Vol.33(6), pp.1071-1093
- DOI
- 10.1016/j.hoc.2019.08.002
- PMID
- 31668207
- PMCID
- PMC6981287
- NLM abbreviation
- Hematol Oncol Clin North Am
- ISSN
- 0889-8588
- eISSN
- 1558-1977
- Publisher
- Elsevier Inc
- Grant note
- DOI: 10.13039/100000005, name: U.S. Department of Defense; DOI: 10.13039/100000002, name: National Institutes of Health; DOI: 10.13039/100007890, name: University of North Carolina at Chapel Hill
- Language
- English
- Date published
- 12/2019
- Academic Unit
- Radiation Oncology
- Record Identifier
- 9984312964802771
Metrics
6 Record Views